Dengue vaccine unit dose and administration thereof
MYPI2025007474A0Undetermined Publication Date: 2020-03-05TAKEDA VACCINES INC
View PDF 0 Cites 0 Cited by
Patent Information
- Application Number
- MYPI2025007474
- Authority / Receiving Office
- MY · MY
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2019-03-07
- Filing Date
- 2019-09-05
- Publication Date
- 2020-03-05
Abstract
The invention relates to a unit dose of a dengue vaccine composition and methods and uses for preventing dengue disease and methods for stimulating an immune response to all four dengue virus serotypes in a subject or subject population. The unit dose of a dengue vaccine composition includes constructs of each dengue serotype, such as TDV-1, TDV-2, TDV-3 and TDV-4, at various concentrations in order to improve protection from dengue infection. Fig. 1
Need to check novelty before this filing date? Find Prior Art
